Divi’s Labs is in the limelight today. The stock which had closed on Friday at Rs.993.90, opened today at Rs.1022.90, its intra day high point.

The good news on the counter is that the company had a successful inspection by the US-FDA for its Unit-2 at Chippada, Bheemunipatnam near Visakhapatnam during February, 2016 with no observations. Currently, with so many companies, coming under the FDA scanner, this “no observation” brings in cheer.

The company had ended Q3FY16 with a 12% (YoY) rise in net profit at Rs.246 crore on a 8% rise in net sales at Rs.852 crore.